ECO Animal Health Group plc (AIM: EAH), a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, conducted an Investor Presentation on 7 September 2022 covering their Audited Results for the period ended 31 March. David Hallas, CEO, and Christopher Wilks, CFO, provided a detailed overview of the operational and financial highlights of the period, discussed the outlook, updated investors on R&D and shared insights on pork pricing & China. The management team also answered questions from the viewing audience.
08 Sep 22